219例泌乳素瘤患者中肿瘤体积与血清泌乳素的相关性及其对手术结局的影响
该研究回顾了2012至2019年单中心219例经蝶窦泌乳素瘤切除术患者,分析肿瘤体积与血清泌乳素水平的相关性及其对生化缓解的影响。结果显示肿瘤体积与泌乳素水平强相关,未缓解患者术前每单位体积泌乳素增幅更大,且ROC曲线确定的预测阈值在Knosp分级≥3的患者中不再显著。
要点
- 肿瘤体积与血清泌乳素水平强相关,体积每增加1 cm3,泌乳素平均增加101.31 µg/L。
- 女性每单位体积泌乳素增幅大于男性(185.70 vs 79.77 µg/L,p < 0.001)。
- 未缓解患者术前每1 cm3肿瘤体积的泌乳素增幅高于缓解患者(111.46 vs 66.08 µg/L)。
核心结论
- 泌乳素瘤体积与血清泌乳素水平存在相关性,但未缓解患者每单位术前肿瘤体积的泌乳素增幅大于缓解患者,提示肿瘤组成不同。
- 作者识别了可最佳预测生化缓解状态的泌乳素和肿瘤体积阈值,并希望其结果可用于识别可通过手术获得缓解、作为药物治疗替代方案的泌乳素瘤。
研究设计与样本
- 单中心回顾性研究,纳入2012至2019年接受经蝶窦泌乳素瘤切除术的219例患者。
- 比较生化缓解与未缓解患者的结果,使用BrainLab Smartbrush量化肿瘤体积,采用相关分析和线性回归检验肿瘤体积与血清泌乳素水平的关联。
- 体积校正泌乳素水平定义为血清泌乳素水平除以肿瘤体积,并使用受试者工作特征(ROC)曲线分析确定预测生化缓解状态的阈值。
主要发现
- 平均肿瘤体积为5.66 cm3,平均术前泌乳素水平为752.3 µg/L。
- 男性泌乳素瘤大于女性(平均体积11.32 vs 2.54 cm3,p < 0.001),女性体积校正泌乳素水平更高(平均412.5 vs 175.9 µg/L/cm3,p < 0.001)。
- 66.7%的手术患者在术后6周达到生化缓解,而同期相似的药物治疗患者缓解率为69.4%。
- Pearson相关和线性回归分析显示术前肿瘤体积与泌乳素水平强相关,肿瘤体积每增加1 cm3,血清泌乳素水平增加101.31 µg/L(p < 0.001);男性R = 0.601(p < 0.001),女性R = 0.935(p < 0.001),女性每1 cm3体积增加对应的泌乳素增幅大于男性(185.70 vs 79.77 µg/L,p < 0.001)。
- 达到缓解的患者术前肿瘤体积每1 cm3对应的术前泌乳素增幅为66.08 µg/L(p < 0.001),低于未缓解患者的111.46 µg/L(p < 0.001);未缓解患者术后残留肿瘤体积每1 cm3对应泌乳素增幅为77.77 µg/L(p < 0.001)。
关键数值与推荐
- ROC曲线分析显示,基于术前泌乳素和肿瘤体积的显著阈值可最佳预测术后未缓解,但这些阈值在Knosp分级≥3的患者中变为不显著。
- 原文未报告具体的阈值数值、灵敏度、特异度或曲线下面积。
临床怎么用
- 作者希望其结果可用于识别可通过手术获得缓解、作为药物治疗替代方案的泌乳素瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Prolactinoma is the most common pituitary adenoma and can be managed medically or surgically. The authors assessed the correlation between tumor volume and prolactin level and its effect on surgical outcomes. METHODS: The authors reviewed 219 patients who underwent transsphenoidal prolactinoma resection at a single institution from 2012 to 2019. Outcomes were compared between patients with and without biochemical remission. Tumor volumes were quantified with BrainLab Smartbrush. Correlation analysis and linear regression were used to examine the association between tumor volume and serum prolactin level. Volume-adjusted prolactin level was defined as serum prolactin level divided by tumor volume. The authors utilized receiver operating characteristic (ROC) curve analysis to determine the thresholds for predicting biochemical remission status. RESULTS: The mean tumor volume was 5.66 cm3, and the mean preoperative prolactin level was 752.3 µg/L. Men had larger prolactinomas than women (mean volume 11.32 vs 2.54 cm3; p < 0.001), and women had a greater volume-adjusted prolactin level (mean 412.5 vs 175.9 µg/L/cm3, p < 0.001). In total, 66.7% of surgical patients achieved biochemical remission 6 weeks after surgery, whereas a similar cohort of medically treated patients during the same time frame demonstrated a 69.4% remission rate. Pearson correlation and linear regression analysis revealed a strong association between preoperative tumor volume and prolactin levels, with an increase in serum prolactin level of 101.31 µg/L per 1-cm3 increase in tumor volume (p < 0.001). This held true for men (R = 0.601, p < 0.001) and women (R = 0.935, p < 0.001), with women demonstrating a greater increase in prolactin level per 1-cm3 increase in volume (185.70 vs 79.77 µg/L, p < 0.001). Patients who achieved remission exhibited a 66.08-µg/L increase in preoperative prolactin level per 1 cm3 of preoperative tumor volume (p < 0.001), which was less than the 111.46-µg/L increase per 1 cm3 in patients without remission (p < 0.001). Patients who failed to achieve remission had residual tumors with a 77.77-µg/L increase in prolactin per 1 cm3 of remaining tumor volume after resection (p < 0.001). ROC curve analysis revealed significant thresholds that optimally predicted lack of postoperative remission on the basis of preoperative prolactin and tumor volume. These thresholds were rendered nonsignificant in patients with documented Knosp grade ≥ 3. CONCLUSIONS: Although the authors found a correlation between prolactinoma volume and serum prolactin level, patients without remission had a greater increase in serum prolactin level per increase in preoperative tumor volume than those who achieved remission, suggesting unique tumor composition. The authors also identified prolactin and tumor volume thresholds that optimally predicted biochemical remission status. The authors hope that their results can be used to identify prolactinomas for which surgery could achieve remission as an alternative to medical management.
引用
- Osorio RC, Pereira MP, Oh T, et al. Correlation between tumor volume and serum prolactin and its effect on surgical outcomes in a cohort of 219 prolactinoma patients. J Neurosurg. 2022. PMID: 36242577. doi:10.3171/2022.8.JNS221890
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。